Clinical Trial Update: Safety Study and Preliminary Efficacy of Infusion Haploidentical Mesenchymal Stem Cells Derived From Bone Marrow for Treating Recessive Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing safety and preliminary efficacy of infusion haploidentical mesenchymal stem cells derived from bone marrow for recessive dyst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Recessive Dystrophic Epidermolysis Bullosa

Drugs mentioned

• mesenchymal stem cells, haploidentical (bone marrow-derived)

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Epidermolysis Bullosa Dystrophica, Recessive | Phase 1, Phase 2 | Status: UNKNOWN